In a report released today, Gil Blum from Needham maintained a Buy rating on Shattuck Labs (STTK – Research Report), with a price target of...
- SL-9258 (TIGIT-Fc-LIGHT) combined with anti-PD(L)1 broadened anti-tumor activity of the checkpoint antibodies...
AUSTIN, TX and DURHAM, NC, April 05, 2022 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (NASDAQ: STTK), a...
STTK SHAREHOLDER ALERT: Jakubowitz Law Reminds Shattuck Shareholders Of A Lead Plaintiff Deadline Of April 1, 2022 PR Newswire NEW YORK, April 1...
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders Of Shattuck Labs, Inc. Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of...
STTK SHAREHOLDER ALERT: Jakubowitz Law Reminds Shattuck Shareholders of a Lead Plaintiff Deadline of April 1, 2022 PR Newswire NEW YORK, March...
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Shattuck Labs, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of...
Needham analyst Gil Blum maintained a Buy rating on Shattuck Labs (STTK – Research Report) today and set a price target of $31.00. The company's...
Table of Contents As filed with the Securities and Exchange Commission on March 15, 2022...
– Presented positive initial dose-escalation clinical data for SL-172154, including high target occupancy...
As filed with the Securities and Exchange Commission on March 15, 2022 Registration No. 333-  ...
AUSTIN, Texas and DURHAM, N.C., March 09, 2022 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ:...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.